TerminatedPhase 2NCT02013375

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Damiano Rondelli, MD
Principal Investigator
Damiano Rondelli, MD
University of Illinois at Chicago
Intervention
Haploidentical Transplant(procedure)
Enrollment
2 target
Eligibility
16-60 years · All sexes
Timeline
2014 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02013375 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials